Skip to the page

Data / Form D filings / Pike Therapeutics Inc.

Pike Therapeutics Inc.: Form D filings

Pike Therapeutics Inc., a technology company in Vancouver, British Columbia, Canada, filed 3 Form D notices with the SEC between 2021 and 2026. The latest, on July 21, 2026, reports $760,000 sold of a $760,000 offering to 5 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
20TH FLOOR, 250 HOWE STREET, Vancouver, British Columbia, Canada, V6C 3
Phone
(416) 509-6509
Industry
Other Technology
Entity type
Corporation
Incorporated in
British Columbia, Canada
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1884336

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jul 21, 2026New notice$760,000$760,0005Jun 30, 2026sec.gov
Sep 5, 2023New notice$100,000$100,0002Aug 21, 2023sec.gov
Sep 24, 2021New notice$174,999$174,9994Aug 4, 2021sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
IAN FODIEExecutive Officer, DirectorCHIEF FINANCIAL OFFICER, SECRETARY
BRADLEY MILESExecutive Officer, DirectorCHIEF EXECUTIVE OFFICER
MARK PURDYDirector

Every Form D from the week of Jul 20, 2026 · All recent Other Technology filings

Read from SEC EDGAR. Amount sold is what Pike Therapeutics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.